| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2024 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 10,000 | $15.67 | $156,700.00 | -7.2% | +32.7% | +43.0% | |
| Apr 12, 2024 | NPCE Neuropace Inc | Orbimed Advisors LLC67 | 10% Owner | Sell | 485,000 | $14.49 | $7,026,032.93 | -6.4% | -45.1% | -22.8% | |
| Apr 11, 2024 | BVS Bioventus Inc. | Singleton Mark Leonard46 | SVP &CFO | Sell | 4,000 | $4.75 | $19,000.00 | -10.3% | +22.5% | +55.5% | |
| Apr 11, 2024 | BVS Bioventus Inc. | D'adamio Anthony61 | SVP &General Counsel | Sell | 3,054 | $4.75 | $14,506.50 | -5.0% | +22.5% | +55.5% | |
| Apr 11, 2024 | NEOG Neogen Corp | Borel James C | Director | Buy | 7,500 | $13.06 | $97,986.00 | +54.0% | +16.7% | -57.1% | |
| Apr 11, 2024 | BVS Bioventus Inc. | Church Katrina J52 | SVP &Chief Compliance Officer | Sell | 1,325 | $4.75 | $6,293.75 | -7.2% | +22.5% | +55.5% | |
| Apr 10, 2024 | NEOG Neogen Corp | Adent John Edward49 | CEO | Buy | 23,000 | $12.36 | $284,190.30 | +17.8% | +17.8% | -55.0% | |
| Apr 10, 2024 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Sell | 12,000 | $95.09 | $1,141,080.00 | -13.9% | +54.5% | -20.2% | |
| Apr 10, 2024 | NEOG Neogen Corp | Naemura David H. | CFO | Buy | 12,500 | $12.51 | $156,321.25 | +71.3% | +17.8% | -55.0% | |
| Apr 9, 2024 | CTKB Cytek Biosciences, Inc. | Yan Ming77 | Chief Technology Officer | Sell | 1,900 | $7.00 | $13,304.00 | - | -15.6% | -45.9% | |
| Apr 9, 2024 | EW Edwards Lifesciences Corp | Lippis Daniel J.62 | Cvp, Japac | Sell | 857 | $92.34 | $79,135.38 | -4.7% | -1.3% | -24.9% | |
| Apr 9, 2024 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 19,900 | $90.35 | $1,798,002.28 | -19.8% | +60.0% | -19.1% | |
| Apr 8, 2024 | ANGO Angiodynamics Inc | Clemmer James C50 | President And CEO | Buy | 10,000 | $6.70 | $67,000.00 | +1.9% | -16.6% | +36.2% | |
| Apr 8, 2024 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 12,500 | $92.33 | $1,154,141.88 | -12.0% | -0.5% | -27.4% | |
| Apr 8, 2024 | GKOS Glaukos Corp | Gilliam Joseph E55 | President &COO | Sell | 59,801 | $100.47 | $6,008,358.86 | -11.4% | +21.8% | -18.2% | |
| Apr 8, 2024 | DXCM Dexcom Inc | Sayer Kevin R62 | President CEO And Chairman | Sell | 49,633 | $138.30 | $6,864,136.11 | -7.8% | -20.7% | -56.6% | |
| Apr 8, 2024 | EW Edwards Lifesciences Corp | Lemercier Jean-Luc M67 | Cvp, Emeacla | Sell | 14,400 | $92.32 | $1,329,471.90 | -3.8% | -0.5% | -27.4% | |
| Apr 8, 2024 | MDT Medtronic Plc | Marinaro Michael | EVP &President, Surgical Ou | Sell | 854 | $83.14 | $71,001.56 | -3.0% | -7.3% | -1.2% | |
| Apr 8, 2024 | GKOS Glaukos Corp | Thurman Alex R.50 | SVP &Chief Financial Officer | Sell | 1,634 | $99.91 | $163,260.46 | -0.6% | +21.8% | -18.2% | |
| Apr 5, 2024 | GKOS Glaukos Corp | Gilliam Joseph E55 | President &COO | Sell | 2,457 | $96.81 | $237,862.17 | -2.4% | +25.8% | -13.6% | |
| Apr 5, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 42,044 | $1.10 | $46,383.39 | - | +8.3% | -37.0% | |
| Apr 4, 2024 | EW Edwards Lifesciences Corp | Mussallem Michael A65 | Director | Sell | 29,350 | $92.42 | $2,712,418.04 | -24.6% | -0.1% | -23.9% | |
| Apr 4, 2024 | GKOS Glaukos Corp | Thurman Alex R.50 | SVP &Chief Financial Officer | Sell | 750 | $95.03 | $71,271.12 | -0.5% | +26.7% | -11.1% | |
| Apr 4, 2024 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 10,000 | $80.21 | $802,084.10 | -16.6% | +93.7% | -12.3% | |
| Apr 4, 2024 | GKOS Glaukos Corp | Gilliam Joseph E55 | President &COO | Sell | 400 | $96.59 | $38,636.00 | -0.2% | +26.7% | -11.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.